ACXP - Acurx Pharmaceuticals GAAP EPS of -$0.37
2024-03-18 11:15:57 ET
More on Acurx Pharmaceuticals
- Acurx Sell-Off Presents Opportunity Before Upcoming Data Release
- Acurx stock plunges 26% amid Phase 2 data release for C. diff drug
- ELAB, KIND and RLX among pre-market losers
- Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals
- Historical earnings data for Acurx Pharmaceuticals